This study describes the design and synthesis of endomorphin-1 analogs containing C-terminal aromatic α-methyl-β-amino acids and an N-terminal native tyrosine or 2,6-dimethyl-tyrosine. We show that, in comparison with the parent peptide, these analogs exhibit improved bioactivity and blood-brain barrier penetration after intravenous administration, and have a lower tendency to induce constipation and sedation than morphine.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/c7ob01115f | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cyclic Glycopeptide Analogs of Endomorphin-1 Provide Highly Effective Antinociception in Male and Female Mice.
ACS Med Chem Lett
October 2024
Department of Chemistry & Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States.
Article Synopsis
- Opioids, particularly those targeting the mu opioid receptor (MOR), are effective for severe pain but have serious side effects that limit their use.
- Researchers developed cyclic glycopeptide endomorphin (glycoEM) analogs that provided pain relief similar to morphine while reducing side effects, including lower abuse potential.
- In studies with male and female mice, two glycoEM analogs exhibited higher potency and longer-lasting pain relief at much lower doses than morphine, suggesting potential for future clinical applications.
Comparison of Morphine and Endomorphin Analog ZH853 for Tolerance and Immunomodulation in a Rat Model of Neuropathic Pain.
J Pain
October 2024
Neuroscience Program/Brain Institute, Tulane University School of Medicine, New Orleans, Louisiana; SE LA Veterans Health Care System, Tulane University School of Medicine, New Orleans, Louisiana; Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana; Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana. Electronic address:
µ-Opioid receptor agonists, the gold standard for analgesia, come with significant side effects when used chronically. Tolerance, defined as the decrease in analgesic activity after repeated use, remains a vital therapeutic obstacle as it increases the likelihood of dose escalation and potentially lethal side effects like respiratory depression. Previous experiments have shown that the endomorphin-1 analog, ZH853, is a specific µ-opioid receptor agonist with reduced side effects like tolerance and glial activation following chronic central administration in pain-naive animals.
View Article and Find Full Text PDFNovel Opioids in the Setting of Acute Postoperative Pain: A Narrative Review.
Pharmaceuticals (Basel)
December 2023
Department of Anesthesiology, Stony Brook University Hospital, Stony Brook, NY 11794, USA.
Although traditional opioids such as morphine and oxycodone are commonly used in the management of acute postoperative pain, novel opioids may play a role as alternatives that provide potent pain relief while minimizing adverse effects. In this review, we discuss the mechanisms of action, findings from preclinical studies and clinical trials, and potential advantages of several novel opioids. The more established include oliceridine (biased ligand activity to activate analgesia and downregulate opioid-related adverse events), tapentadol (mu-opioid agonist and norepinephrine reuptake inhibitor), and cebranopadol (mu-opioid agonist with nociceptin opioid peptide activity)-all of which have demonstrated success in the clinical setting when compared to traditional opioids.
View Article and Find Full Text PDFTrifluoromethylthiolation of Tryptophan and Tyrosine Derivatives: A Tool for Enhancing the Local Hydrophobicity of Peptides.
J Org Chem
September 2023
CY Cergy Paris Université, CNRS, BioCIS, Cergy Pontoise 95000, France.
The incorporation of fluorinated groups into peptides significantly affects their biophysical properties. We report herein the synthesis of Fmoc-protected trifluoromethylthiolated tyrosine (CFS-Tyr) and tryptophan (CFS-Trp) analogues on a gram scale (77-93% yield) and demonstrate their use as highly hydrophobic fluorinated building blocks for peptide chemistry. The developed methodology was successfully applied to the late-stage regioselective trifluoromethylthiolation of Trp residues in short peptides (66-80% yield) and the synthesis of various CFS-analogues of biologically active monoamines.
View Article and Find Full Text PDFContribution of the μ opioid receptor and enkephalin to the antinociceptive actions of endomorphin-1 analogs with unnatural amino acid modifications in the spinal cord.
Peptides
July 2021
Department of Pharmacology, Key Laboratory of Preclinical Study for New Drugs of Gansu Province, Institute of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, 730000, PR China. Electronic address:
Endomorphin analogs containing unnatural amino acids have demonstrated potent analgesic effects in our previous studies. In the present study, the differences in antinociception and the mechanisms thereof for analogs 1-3 administered intracerebroventricularly and intrathecally were explored. All analogs at different routes of administration produced potent analgesia compared to the parent peptide endomorphin-1.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!